Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method.
暂无分享,去创建一个
D. Finegood | D. Tzur | D T Finegood | D Tzur
[1] R N Bergman,et al. Estimation of Endogenous Glucose Production During Hyperinsulinemic-Euglycemic Glucose Clamps: Comparison of Unlabeled and Labeled Exogenous Glucose Infusates , 1987, Diabetes.
[2] R N Bergman,et al. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. , 1986, Computer methods and programs in biomedicine.
[3] I. Godsland,et al. Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity. , 1994, Metabolism: clinical and experimental.
[4] R N Bergman,et al. Importance of Glucose Per Se to Intravenous Glucose Tolerance: Comparison of the Minimal-Model Prediction with Direct Measurements , 1985, Diabetes.
[5] D. Owens,et al. Comparison of Estimates of Insulin Sensitivity From Minimal Model Analysis of the Insulin-Modified Frequently Sampled Intravenous Glucose Tolerance Test and the Isoglycemic Hyperinsulinemic Clamp in Subjects With NIDDM , 1995, Diabetes.
[6] R N Bergman,et al. The Insulin Sensitivity Index: Correlation in Dogs Between Values Determined from the Intravenous Glucose Tolerance Test and the Euglycemic Glucose Clamp , 1984, Diabetes.
[7] R. Bergman,et al. Modeling Error and Apparent Isotope Discrimination Confound Estimation of Endogenous Glucose Production During Euglycemic Glucose Clamps , 1988, Diabetes.
[8] C Cobelli,et al. Minimal Models of Glucose Disappearance: Lessons from the Labelled IVGTT , 1991, Diabetic medicine : a journal of the British Diabetic Association.
[9] R N Bergman,et al. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. , 1987, The Journal of clinical investigation.
[10] I. Hramiak,et al. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. , 1990, The Journal of clinical endocrinology and metabolism.
[11] R. Bergman,et al. Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. , 1990, The Journal of clinical endocrinology and metabolism.
[12] R N Bergman,et al. The Insulin Sensitivity Index in Nondiabetic Man: Correlation Between Clamp-derived and IVGTT-derived Values , 1986, Diabetes.
[13] R N Bergman,et al. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. , 1990, The Journal of clinical endocrinology and metabolism.
[14] S. Kahn,et al. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. , 1994, The Journal of clinical investigation.
[15] K. Tokuyama,et al. Insulin sensitivity, insulin secretion, and glucose effectiveness in anorexia nervosa: a minimal model analysis. , 1993, Metabolism: clinical and experimental.
[16] H. Imura,et al. Insulin sensitivity, insulin secretion, and glucose effectiveness in subjects with impaired glucose tolerance: a minimal model analysis. , 1994, Metabolism: clinical and experimental.
[17] D. Finegood,et al. Insulin Sensitivity and Glucose Effectiveness in Long-Term Islet-Autotransplanted Dogs , 1989, Diabetes.
[18] D. Finegood,et al. Reduced Insulin Secretion by Repeated Low Doses of STZ Impairs Glucose Effectiveness but Does Not Induce Insulin Resistance in Dogs , 1993, Diabetes.